MBX Biosciences, Inc. Common Stock
USD30.05
-0.65 (-2.12%)
CEO
Peter Kent Hawryluk
IPO Date
2000-01-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$30.53
Prev. Close
$30.70
Day Low
$29.56
Day High
$30.83
52W Low
$9.43
52W High
$45.85
Market Cap
$1.01B
Volume
0.44M
| 55,000 |
| $38.38 |
| 11 May 2026 | Azoulay Salomon | Chief Medical Officer | M-Exempt | Acquired | 15,003 | $16.00 |
| 11 May 2026 | Azoulay Salomon | Chief Medical Officer | S-Sale | Disposed | 15,003 | $38.30 |
| 11 May 2026 | Azoulay Salomon | Chief Medical Officer | M-Exempt | Acquired | 55,000 | $10.46 |
| 11 May 2026 | Azoulay Salomon | Chief Medical Officer | M-Exempt | Acquired | 15,003 | $16.00 |
| 8 May 2026 | Azoulay Salomon | Chief Medical Officer | S-Sale | Disposed | 231 | $29.54 |
| 8 May 2026 | Hawryluk P. Kent | director, officer: President & CEO | S-Sale | Disposed | 607 | $29.54 |
| 4 May 2026 | Hoerter Steven L. | director | A-Award | Acquired | 11,938 | $0.00 |
| 4 May 2026 | Hoerter Steven L. | director | A-Award | Acquired | 74,249 | $29.78 |